Rohto Pharmaceutical Co (TSE:4527) Total Debt per Share : 円42.22 (As of Dec. 2023)

View and export this data going back to 1962. Start your Free Trial

What is Rohto Pharmaceutical Co Total Debt per Share?

円42.22 (As of Dec. 2023)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Rohto Pharmaceutical Co's Total Debt Per Share for the quarter that ended in Dec. 2023 was 円42.22.

Rohto Pharmaceutical Co Total Debt per Share Historical Data

The historical data trend for Rohto Pharmaceutical Co's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rohto Pharmaceutical Co Total Debt per Share Chart

Rohto Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Debt per Share

Get a 7-Day Free Trial

22.68

31.98

35.50

93.73

51.25

Rohto Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Debt per Share	Get a 7-Day Free Trial															68.83	51.25	48.68	43.81	42.22

Rohto Pharmaceutical Co Total Debt per Share Calculation

Rohto Pharmaceutical Co's Total Debt Per Share for the fiscal year that ended in Mar. 2023 is calculated as:

Total Debt Per Share	=	(Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation)	/	Shares Outstanding (EOP)
	=	(7,516	+	4,177)	/	228
	=	51.25

Rohto Pharmaceutical Co's Total Debt Per Share for the quarter that ended in Dec. 2023 is calculated as:

Total Debt Per Share	=	(Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation)	/	Shares Outstanding (EOP)
	=	(5,273	+	4,359)	/	228
	=	42.22

Rohto Pharmaceutical Co Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Rohto Pharmaceutical Co's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Rohto Pharmaceutical Co (TSE:4527) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Rohto Pharmaceutical Co Ltd (TSE:4527) » Definitions » Total Debt per Share

Comparable Companies

Traded in Other Exchanges

4527:Mexico

Address

1-8-1, Tatsumi-nishi, Ikuno-ku, Osaka, JPN, 544-8666

Website

https://www.rohto.co.jp

Rohto Pharmaceutical Co Ltd is a Japan-based manufacturer and marketer of pharmaceutical products, cosmetics, and functional foods. It undertakes manufacture and sales activities mainly in the health and beauty care categories. The company comprises the four geographical reportable segments of Japan, America, Europe, and Asia. In each segment, it manufactures and sales eye care products including eye drops and eyewash preparations, skincare products including dermal medicines, lip balm, sunscreens, and functional cosmetics, among others, internal medicines and food products including gastrointestinal medicines, traditional Chinese herbal medicines and supplements, and other products and services, such as in-vitro test kits.

Rohto Pharmaceutical Co (TSE:4527) Headlines

No Headlines